BioForm Medical has created a product that has been tested and proven to successfully treat specific types of varicose veins and spider veins in a diverse range of patients. The product, polidocanol, showed a minimum of 95% effectiveness in treating these vein problems.
It was actually fairly well known that this product was going to do well in testing due to the fact that it has been used for this exact purpose in Europe for the past four decades or more. However, testing here hadn't been complete until recently so it has not been a viable vein treatment option for patients in the United States.
It should be noted that this is a sclerotherapy product. It is intended to replace the ingredients used in today's leading sclerotherapy products. However, sclerotherapy is not the only method of treating vein problems and may not even be the most popular method here in the United States due to the prevalence of such procedures as VNUS Closure Fast.
Question of the Day: Why did it take so long for the U.S. to test this product when Europe has been using it to treat vein problems for so long?
